Abstract
Background and purpose: Placenta accreta spectrum (PAS) is an abnormal placental adherence or invasion of the myometrium or extrauterine structures. Its prevalence increases proportionally to the number of cesarean sections. The aim of this retrospective cohort study was to evaluate maternal and neonatal outcomes in patients with placenta previa and placenta accreta.
Methods: A retrospective analysis of patients with placental attachment disorders was performed in the Training and Research Hospital. Data collection was performed using the medical records of patients with placenta accreta and previa, analyzing maternal and neonatal outcome.
Results: Five cases of placenta previa accreta were identified in the last 3 years out of a total of 5,235 deliveries. The mean maternal age was 35.3 years and the gestational age ranged from 27 to 39 weeks. Five cases were diagnosed prenatally by ultrasonography or MRI. Three had hysterectomies during the intrapartum period, and two cases were treated conservatively. Bilateral hypogastric artery ligation was performed in three cases.
Conclusion: Placenta accreta spectrum (PAS) is an abnormal placental adherence or invasion of the myometrium or extrauterine structures. Prenatal diagnosis of PAS is essential to plan delivery in a competent tertiary care center.
References
Pain FA, Dohan A, Grange G, et al. Percreta score to differentiate between placenta accreta and placenta percreta with ultrasound and MR imaging. Acta Obstet Gynecol Scand. 2022;101:1135-45.
Chalubinski KM, Pils S, Klein K, et al. Prenatal sonography can predict degree of placental invasion. Ultrasound Obstet Gynecol. 2013;42:518-24.
Jauniaux E, Grønbeck L, Bunce C, Langhoff-Roos J, Collins SL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open. 2019;9:e031193.
Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217:27-36.
Silver RM, Barbour KD. Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2015;42:381-402.
Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177:210-4.
Srisajjakul S, Prapaisilp P, Bangchokdee S. Magnetic resonance imaging of placenta accreta spectrum: a step-by-step approach. Korean J Radiol. 2021;22:198-212.
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75-87.
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014;121:62-70; discussion 70-1.
Silver RM, Landon MB, Rouse DJ, et al.; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226-32.
Govindappagari S, Wright JD, Ananth CV, Huang Y, DʼAlton ME, Friedman AM. Risk of peripartum hysterectomy and center hysterectomy and delivery volume. Obstet Gynecol. 2016;128:1215-24.
Sichitiu J, El-Tani Z, Mathevet P, Desseauve D. Conservative surgical management of placenta accreta spectrum: a pragmatic approach. J Invest Surg. 2021;34:172-80.
Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115:526-34.
Clausen C, Lönn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014;93:138-43.
Kallianidis AF, Maraschini A, Danis J, et al.; INOSS (the International Network of Obstetric Survey Systems). Management of major obstetric hemorrhage prior to peripartum hysterectomy and outcomes across nine European countries. Acta Obstet Gynecol Scand. 2021;100:1345-54.
Caliskan E, Tan O, Kurtaran V, Dilbaz B, Haberal A. Placenta previa percreta with urinary bladder and ureter invasion. Arch Gynecol Obstet. 2003;268:343-4.
Smith ZL, Sehgal SS, Van Arsdalen KN, Goldstein IS. Placenta percreta with invasion into the urinary bladder. Urol Case Rep. 2014;2:31-2.
Jauniaux E, Collins SL, Jurkovic D, Burton GJ. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016;215:712-21.
Thiravit S, Ma K, Goldman I, et al. Role of ultrasound and MRI in diagnosis of severe placenta accreta spectrum disorder: an intraindividual assessment with emphasis on placental bulge. AJR Am J Roentgenol. 2021;217:1377-88.
Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta. Obstet Gynecol 2012;120:207-11.
Blackwell SC. Timing of delivery for women with stable placenta previa. Semin Perinatol. 2011;35:249-51.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Cem Dame, Emrah Kızıldag˘, Sinan Güleç, Banu Dane